Whang-Peng states that cancer is the world's leading killer. Considering the urgency of saving lives, most countries are quite lenient about approving new cancer drugs, but Taiwan is very strict. In addition to local clinical trials, clinical trials in two Southeast Asian countries must be completed before they can be released into Taiwan's market, eliciting criticism that it's too slow given the urgency of the situation.
彭汪嘉康指出，癌症是本世紀的頭號殺手，基於急於救命的考量，一般國家對於癌症新藥上市的審核多半較為寬鬆，但台灣仍然把關很嚴格，除了要在本地做臨床試驗外，還要在東南亞其他 2 個國家通過臨床測試才能在台灣上市，有時難免讓人有「緩不濟急」的慨嘆。